This study will investigate the safety and efficacy of a new investigational medicine in adults who are living with obesity or excess weight with at least one weight-related medical condition (such as cardiovascular disease (CVD) or high blood pressure).
LAA2 is a new clinical research study from Eli Lilly and Company. It is testing if an investigational medicine (a medicine being studied) may help treat people with obesity or overweight and type 2 diabetes.
TRIUMPH-3 is a clinical research study for people with excess weight and heart disease. The study will test how safe and well the investigational medicine (the medicine being studied) works for weight management.
The SURMOUNT-MMO Study is evaluating the effectiveness of an investigational medication (trial treatment) on reducing health risks that are commonly found in people who are living with obesity or are overweight. This clinical trial is focusing particularly on cardiovascular (heart) disease and other heart health risks.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)